Detalles de la búsqueda
1.
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 63(1): 140-148, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37140539
2.
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort).
J Rheumatol
; 51(5): 462-471, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359938
3.
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study.
J Am Acad Dermatol
; 90(5): 945-952, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340127
4.
Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study.
Health Qual Life Outcomes
; 18(1): 4, 2020 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31900174
5.
Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild-to-moderate atopic dermatitis.
Pediatr Dermatol
; 37(6): 1030-1037, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32981097
6.
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial.
J Allergy Clin Immunol
; 144(5): 1274-1289, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31419544
7.
Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis.
Ann Rheum Dis
; 77(2): 221-227, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28970213
8.
Sustained remission with etanercept tapering in early rheumatoid arthritis.
N Engl J Med
; 371(19): 1781-92, 2014 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25372086
9.
Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Rheumatol Int
; 37(9): 1469-1479, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28597306
10.
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.
Ann Rheum Dis
; 75(7): 1328-35, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26269397
11.
Skin permeation and penetration of crisaborole when coapplied with emollients.
J Am Acad Dermatol
; 83(6): 1801-1803, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33069458
12.
Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials.
Mod Rheumatol
; 25(2): 173-86, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24842477
13.
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
Lancet
; 381(9870): 918-29, 2013 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23332236
14.
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.
Ann Rheum Dis
; 73(6): 1114-22, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23696632
15.
Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
J Clin Rheumatol
; 20(1): 25-33, 2014 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356474
16.
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies.
Rheumatol Ther
; 11(3): 583-597, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38488976
17.
Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis.
Dermatitis
; 35(1): 84-91, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38206678
18.
Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 14(4): 875-892, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546803
19.
Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis.
BMC Musculoskelet Disord
; 14: 13, 2013 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23294908
20.
A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis.
Mod Rheumatol
; 23(4): 623-33, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23011358